Mealey's (March 3, 2021, 11:50 AM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals in a March 1 holding left intact a jury’s verdict that a Bayer Healthcare LLC patent directed to recombinant forms of...
Recombinant Liver Protein Patent Valid, Infringed, Panel Affirms
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login